BioStar wraps up fifth fund at $130.3m

BioStar Capital is focused on medical technologies primarily in the fields of cardiovascular disease, orthopedics, and robotics.

To read this article, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to read this article and more for free.

Share this